Literature DB >> 25024627

Drain amylase value as an early predictor of pancreatic fistula after cephalic duodenopancreatectomy.

Vladimir D Dugalic1, Djordje M Knezevic1, Vladan N Obradovic1, Miroslava G Gojnic-Dugalic1, Slavko V Matic1, Aleksandra R Pavlovic-Markovic1, Predrag D Dugalic1, Srbislav M Knezevic1.   

Abstract

AIM: To determine predictors of clinically relevant pancreatic fistulas (CRPF) by measuring drain fluid amylase (DFA) in the early postoperative period.
METHODS: This prospective clinical study included 382 patients with periampullary tumors that were surgically resected at our department between March 2005 and October 2012. A cephalic duodenopancreatectomy (DP) was performed on all patients. Two closed suction drains were placed at the end of the surgery. The highest postoperative DFA value was recorded and analyzed during the first three postoperative days and on subsequent days if the drains were kept longer. Pancreatic fistula (PF) was classified according to the International Study Group of Pancreatic Fistula (ISGPF) criteria. Postoperative complications were defined according to the Dindo-Clavien classification. All data were statistically analyzed. The optimal thresholds of DFA levels on the first, second and third postoperative days were estimated by constructing receiver operating curves, generated by calculating the sensitivities and specificities of the DFA levels. The DFA level limits were used to differentiate between the group without PF and the groups with biochemical pancreatic fistula (BPF) and CRPF.
RESULTS: Pylorus-preserving duodenopancreatectomy was performed on 289 (75.6%) patients, while the remaining patients underwent a classic Whipple procedure (CW). The total incidence of PF was 37.7% (grade A 22.8%, grade B 11.0% and grade C 3.9%). Soft pancreatic texture (SPT) was present in 58.3% of patients who developed PF. Mortality was 4.2%. The median DFA value on the first postoperative day (DFA1) in patients who developed PF was 4520 U/L (range 350-99000 U/L) for grade A fistula (BPF) with a SPT and a diameter of the main pancreatic duct (MPD) of ≤ 3 mm. For grade B/C (CRPF), the median DFA1 value was 8501 U/L (range 377-92060 U/L) with a SPT and MPD of ≤ 3 mm. These values were significantly higher when compared to the patients who did not have PF (122; range 5-37875 U/L). The upper limit of DFA values for the first 3 postoperative days in the examined stages of PF were: DFA1 1200 U/L for the BPF and CRPF; DFA3 350 U/L for BPF and DFA3 800 U/L for CRPF. The determined values were highly significant and demonstrated a reliable diagnostic test for both BPF and CRPF.
CONCLUSION: DFA1 ≥ 1200 U/L is an important predictive factor for PF of any degree. The trend of DFA3 (decrease of < 50%) compared to DFA1 is a significant factor in the differentiation of CRPF from transient BPF.

Entities:  

Keywords:  Cephalic duodenopancreatectomy; Drain fluid amylase level; Pancreatic fistula; Periampullary tumors; Prediction

Mesh:

Substances:

Year:  2014        PMID: 25024627      PMCID: PMC4093722          DOI: 10.3748/wjg.v20.i26.8691

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  38 in total

1.  Clinically relevant pancreas-related infectious complication after pancreaticoenteral anastomosis could be predicted by the parameters obtained on postoperative day 3.

Authors:  Takehiro Noji; Toru Nakamura; Yoshiyasu Ambo; On Suzuki; Fumitaka Nakamura; Akihiro Kishida; Satoshi Hirano; Satoshi Kondo; Nobuichi Kashimura
Journal:  Pancreas       Date:  2012-08       Impact factor: 3.327

2.  Drain data to predict clinically relevant pancreatic fistula.

Authors:  Daniel J Moskovic; Sally E Hodges; Meng-Fen Wu; F Charles Brunicardi; Susan G Hilsenbeck; William E Fisher
Journal:  HPB (Oxford)       Date:  2010-09       Impact factor: 3.647

3.  Multivariate logistic regression analysis for prediction of clinically relevant pancreatic fistula in the early phase after pancreaticoduodenectomy.

Authors:  Hisashi Kosaka; Nobukazu Kuroda; Kazuhiro Suzumura; Yasukane Asano; Toshihiro Okada; Jiro Fujimoto
Journal:  J Hepatobiliary Pancreat Sci       Date:  2013-06-26       Impact factor: 7.027

4.  Options and limitations in applying the fistula classification by the International Study Group for Pancreatic Fistula.

Authors:  Florian Gebauer; Katja Kloth; Michael Tachezy; Yogesh K Vashist; Guellue Cataldegirmen; Jakob R Izbicki; Maximilliam Bockhorn
Journal:  Ann Surg       Date:  2012-07       Impact factor: 12.969

5.  Proposal for definition and severity grading of pancreatic anastomosis failure and pancreatic occlusion failure.

Authors:  Steven M Strasberg; David C Linehan; Pierre-Alain Clavien; Jeffrey S Barkun
Journal:  Surgery       Date:  2007-03-09       Impact factor: 3.982

6.  How do we predict the clinically relevant pancreatic fistula after pancreaticoduodenectomy?--an analysis in 244 consecutive patients.

Authors:  Manabu Kawai; Masaji Tani; Seiko Hirono; Shinomi Ina; Motoki Miyazawa; Hiroki Yamaue
Journal:  World J Surg       Date:  2009-12       Impact factor: 3.352

7.  Duct-to-mucosa pancreaticojejunostomies with a hard pancreas and dilated pancreatic duct and duct-to-mucosa pancreaticojejunostomies with a soft pancreas and non-dilated duct.

Authors:  A Hayashibe; M Kameyama
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

8.  Impact of postoperative pancreatic fistula on surgical outcome--the need for a classification-driven risk management.

Authors:  Andreas Schmid Frymerman; Jochen Schuld; Patrick Ziehen; Otto Kollmar; Christoph Justinger; Marco Merai; Sven Richter; Martin Karl Schilling; Mohammed Reza Moussavian
Journal:  J Gastrointest Surg       Date:  2010-01-22       Impact factor: 3.452

9.  The latent presentation of pancreatic fistulas.

Authors:  W B Pratt; M P Callery; C M Vollmer
Journal:  Br J Surg       Date:  2009-06       Impact factor: 6.939

10.  Utility of drain fluid amylase measurement on the first postoperative day after pancreaticoduodenectomy.

Authors:  Robert P Sutcliffe; Narendra Battula; Ali Haque; Amir Ali; Parthi Srinivasan; Simon W Atkinson; Mohamed Rela; Nigel D Heaton; Andreas A Prachalias
Journal:  World J Surg       Date:  2012-04       Impact factor: 3.352

View more
  6 in total

Review 1.  Amylase in drain fluid for the diagnosis of pancreatic leak in post-pancreatic resection.

Authors:  Tsetsegdemberel Bat-Ulzii Davidson; Mohammad Yaghoobi; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-04-07

Review 2.  Endoscopic retrograde pancreatography: When should we do it?

Authors:  Renáta Bor; László Madácsy; Anna Fábián; Attila Szepes; Zoltán Szepes
Journal:  World J Gastrointest Endosc       Date:  2015-08-25

3.  Predictors and Outcomes of Pancreatic Fistula Following Pancreaticoduodenectomy: a Dual Center Experience.

Authors:  Suneed Kumar; Abhijit Chandra; Shibumon M Madhavan; Dinesh Kumar; Smita Chauhan; Anshuman Pandey; Shakeel Masood
Journal:  Indian J Surg Oncol       Date:  2020-08-27

Review 4.  Predictive value of drain pancreatic amylase concentration for postoperative pancreatic fistula on postoperative day 1 after pancreatic resection: An updated meta-analysis.

Authors:  Yao Liu; Yang Li; Ling Wang; Ci-Jun Peng
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

Review 5.  Systematic Review and Meta-Analysis of Pancreatic Amylase Value on Postoperative Day 1 After Pancreatic Resection to Predict Postoperative Pancreatic Fistula.

Authors:  Xiongxiong Lu; Xinjing Wang; Yuan Fang; Hao Chen; Chenghong Peng; Hongwei Li; Xiaxing Deng; Baiyong Shen
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

6.  Preoperative Computed Tomography Imaging of the Pancreas Identifying Predictive Factors for the Progression of Grade A, or Biochemical Leak, to Grade B Postoperative Pancreatic Fistula Following Pancreaticoduodenectomy: A Retrospective Study.

Authors:  Feng-Hao Liu; Xiao-Zhong Jiang; Bin Huang; Yu Yu
Journal:  Med Sci Monit       Date:  2021-02-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.